Janney Montgomery Scott’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,571
Closed -$605K 2279
2020
Q3
$605K Buy
7,571
+494
+7% +$41K ﹤0.01% 1344
2020
Q2
$627K Buy
7,077
+784
+12% +$70.4K ﹤0.01% 1257
2020
Q1
$592K Buy
6,293
+207
+3% +$19.2K ﹤0.01% 1140
2019
Q4
$657K Buy
6,086
+959
+19% +$97.2K ﹤0.01% 1287
2019
Q3
$491K Buy
5,127
+92
+2% +$8.55K ﹤0.01% 1399
2019
Q2
$482K Buy
5,035
+372
+8% +$31.3K ﹤0.01% 1450
2019
Q1
$412K Sell
4,663
-1,020
-18% -$89.7K ﹤0.01% 1497
2018
Q4
$472K Buy
5,683
+688
+14% +$60.6K ﹤0.01% 1333
2018
Q3
$471K Buy
4,995
+786
+19% +$75.1K ﹤0.01% 1476
2018
Q2
$464K Buy
4,209
+66
+2% +$6.89K ﹤0.01% 1438
2018
Q1
$410K Sell
4,143
-1,535
-27% -$137K ﹤0.01% 1430
2017
Q4
$462K Sell
5,678
-189
-3% -$14.8K ﹤0.01% 1345
2017
Q3
$432K Buy
5,867
+1,920
+49% +$138K ﹤0.01% 1335
2017
Q2
$286K Buy
3,947
+335
+9% +$22K ﹤0.01% 1459
2017
Q1
$225K Buy
3,612
+664
+23% +$41.8K ﹤0.01% 1559
2016
Q4
$214K Buy
+2,948
New +$192K ﹤0.01% 1512

Other funds holding UTMD

Janney Montgomery Scott's UTMD Position: Q4 2020 in Review

Janney Montgomery Scott sold out of Utah Medical Products (UTMD) in Q4 2020, closing a stake of 7,571 shares — an estimated $605K sold.

Janney Montgomery Scott first reported a position in UTMD in Q4 2016 and held it in 16 quarters. The position peaked at $657K in Q4 2019. 77 funds tracked by Wall St. Rank hold UTMD as of Q4 2020.

  • Janney Montgomery Scott reported no remaining Utah Medical Products position as of Q4 2020 after selling out during the quarter.
  • Janney Montgomery Scott sold 7,571 Utah Medical Products shares in Q4 2020, an estimated $605K.
  • Janney Montgomery Scott first reported a position in Utah Medical Products in Q4 2016 and held it in 16 quarters.
  • Janney Montgomery Scott's Utah Medical Products position peaked at $657K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2020.

Based on Janney Montgomery Scott's 13F filing for Q4 2020, filed 25 Jan 2021.